Let's begin. Development strategy of pharmaceutical companies under the new policy

With the reform of drug administration and the rewriting of the rules of the game, the competition in the pharmaceutical market is becoming more and more fierce, and the pharmaceutical marketing in China may be reshuffled In the post Jianghu era, how does the new management mode guide the marketing practice? The salon meeting with the theme of "development strategy of pharmaceutical companies under the new deal" hosted by yaozhi.com and Changlong Jinkai international enterprise park is held on yaozhi.com today The meeting is a gathering of industry elites, which is generously shared by many experts A high-quality information exchange platform is built to facilitate in-depth exchanges among enterprises The salon is a small high-end exchange meeting, but in order to share industry information with more colleagues, Yaozhi salon introduced live broadcast mode for the first time, 10000 people online The host Zhang Lin (president of Nan'an District Pharmaceutical Industry Association) came to the stage and opened the meeting Zhang Lin, chairman of Nan'an District Pharmaceutical Industry Association, opened the meeting with Li Tianquan, co-founder and vice president of pharmaceutical intelligence network, who made a macro analysis of the current pharmaceutical pattern and delivered a speech on the theme of "looking at the industrial impact of new medical policies through data" At present, pharmaceutical enterprises are faced with severe pharmaceutical policies and tortuous road of consistency evaluation 4 + 7 collective procurement has strengthened government guidance The auxiliary drug catalog involves a huge amount of sales The pharmaceutical intelligence data analysis has sorted out the key monitoring drug catalog, bringing convenient services to colleagues in the industry The trend is more logical than the policy and deserves our attention With the domestic enterprises in line with the international standards, the market tends to be standardized, the profit of generic drugs is further reduced, and the sales drive is turned to product drive In the face of various market difficulties, pharmaceutical intelligence network relies on big data to provide data analysis, resource docking and other services for enterprises, and help enterprises to make decisions Li Zhaojun, co-founder and vice president of yaozhi.com, Li Tianquan, chief executive officer of yaozhi.com (Shanghai) Technology Development Co., Ltd., deeply explored the investment logic of the pharmaceutical market and brought the keynote speech of "organization restart and human finance of pharmaceutical enterprises" In the future, the enterprise model will move towards the trend of enterprise platform, industrial ecology and employee creation The key is to improve efficiency, reduce cost, flexible deployment and risk control Mr Li Zhaojun, combined with specific examples, guided the guests to divide their business reasonably, transformed the industrial relations into civil cooperative relations, obtained the mode upgrading and cost advantage through organization restart, released the labor, organization and performance relations, and stimulated the entrepreneurial potential of employees through organization platform Li Zhaojun, chief executive officer of pay soft (Shanghai) Technology Development Co., Ltd., followed by Chen ya, investment manager of Changlong Jinkai International Enterprise Park, introduced the park in detail Changlong Jinkai international enterprise park is located in the core area of Nan'an tea garden, focusing on the development of medicine circulation and medical device research and development The construction of the park is expected to be completed by the end of the year, and the investment attraction is started After Mr Chen's introduction, when he entered the tea break, the elites here passed on business cards to each other and reached a match of contacts and resources After Chen ya, the investment manager of Changlong Jinkai International Enterprise Park, and Xian Yi, the deputy general manager of Chongqing Economic Development Zone Investment Promotion Co., Ltd., made relevant introduction to the development and investment policies of large-scale health industry in the economic development zone The economic development zone in Nan'an District of Chongqing enjoys a pleasant environment and convenient transportation It is the only "releasing management service" Reform Experimental Zone in the city, and also the superposition zone of western development, free trade zone and national economic and Technological Development Zone It focuses on the development of big data, big health, modern service and other industries, and relevant platforms have successively settled in recent years Xu Jianhua, deputy general manager of Chongqing Economic Development Zone Investment Promotion Co., Ltd., a consultant and researcher of Xianyi pharmaceutical intelligence, looks at new drug marketing, discusses drug market research and market analysis, and brings the theme sharing of agency product selection and analysis It is very important to make a scientific judgment on the information source of agent products Enterprises should conduct self-assessment, specify product boundaries, and use tools to study the dimensions of agent product selection Combined with specific examples, this paper gives suggestions on evaluation before implementation, and provides professional and efficient consulting services for enterprises relying on the pharmaceutical intelligence consulting expert team Xu Jianhua, a researcher of pharmaceutical intelligence consulting, introduced a new pharmaceutical marketing model for the guests on site and innovated the pharmaceutical circulation channels At the end of the speech, we felt that we had gained a lot Several guests expressed their feelings and actively discussed with you In the sound of heated discussion, the salon ended.